Inspire Medical Systems, Inc. Common Stock (INSP)
61.79
-5.42 (-8.06%)
NYSE · Last Trade: Nov 3rd, 3:44 PM EST
News & Press Releases
INSP Q3 deep dive: coding stabilization and patient flow initiatives set stage for 2027 growth
Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q3 2026 results topping the market’s revenue expectations, but sales fell by 7.9% yea...
Via StockStory · November 3, 2026
Inspire (INSP) Q3 2026 Earnings Call Transcriptfool.com
Reimbursement headwinds cut Q3 revenue, but 2027 outlook improves.
Via The Motley Fool · November 3, 2026
Inspire Medical Systems Q3 Earnings Call Highlightsmarketbeat.com
Inspire Medical Systems (NYSE:INSP) reported third-quarter revenue of $206.7 million, down 7.9% from a year earlier but up 3% sequentially, as stronger-than-expected U.S. performance offset weaker international results. The company said coding and reimbursement challenges continued to weigh on resul
Via MarketBeat · November 2, 2026
Inspire Medical Systems (NYSE:INSP) beats Q3 2026 sales expectations
Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q3 2026 results exceeding the market’s revenue expectations, but revenue fell by 7.9%...
Via StockStory · November 2, 2026
Inspire Medical Systems earnings: what to look for from INSP
Medical technology company Inspire Medical Systems (NYSE:INSP) will be reporting results tomorrow after market close. Here’s what you need to know. Inspire M...
Via StockStory · November 1, 2026
2 high-flying stocks on our watchlist and 1 we turn down
Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expecta...
Via StockStory · October 30, 2026
3 healthcare stocks we keep off our radar
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva...
Via StockStory · October 26, 2026
3 Cash-Heavy Stocks We Steer Clear Of
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion o...
Via StockStory · October 8, 2026
1 Profitable Stock Worth Your Attention and 2 We Ignore
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via StockStory · October 6, 2026
Medical Devices & Supplies - Specialty Stocks Q2 Earnings Review: Inspire Medical Systems (NYSE:INSP) Shines
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - specialty industry, including In...
Via StockStory · October 4, 2026
1 Momentum Stock to Target This Week and 2 That Underwhelm
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such a...
Via StockStory · September 22, 2026
Why Inspire Medical Systems (INSP) Stock Is Up Today
What Happened? Shares of medical technology company Inspire Medical Systems (NYSE:INSP) jumped 7.4% in the morning session after Stifel analyst Jonathan Bloc...
Via StockStory · September 11, 2026
Inspire Medical Systems (INSP): Buy, Sell, or Hold Post Q2 Earnings?
Inspire Medical Systems currently trades at $62.14 per share and has shown little upside over the past six months, posting a small loss of 3.4%. The stock al...
Via StockStory · September 4, 2026
3 Cash-Producing Stocks That Concern Us
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via StockStory · August 25, 2026
1 Unpopular Stock That Deserves Some Love and 2 We Avoid
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea...
Via StockStory · August 24, 2026
Winners And Losers Of Q2: Haemonetics (NYSE:HAE) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Haemonetics (NYSE:HAE) and it...
Via StockStory · August 20, 2026
1 Healthcare Stock for Long-Term Investors and 2 Facing Challenges
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...
Via StockStory · August 20, 2026
Inspire Medical Systems (INSP) Q2 2026 Earnings Call Transcriptfool.com
Revenue fell 7.6% on coding disruptions, but management raised full-year guidance.
Via The Motley Fool · August 10, 2026
5 Insightful Analyst Questions From Inspire Medical Systems’s Q2 Earnings Call
Inspire Medical Systems’ second quarter results were marked by improved coding clarity and cost discipline, which management credited as key drivers behind t...
Via StockStory · August 10, 2026
1 Cash-Heavy Stock with Exciting Potential and 2 We Question
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they strugg...
Via StockStory · August 10, 2026
Why Are Inspire Medical Systems (INSP) Shares Soaring Today
What Happened? Shares of medical technology company Inspire Medical Systems (NYSE:INSP) jumped 18.3% in the morning session after the company reported an imp...
Via StockStory · August 4, 2026
Inspire Medical Systems Q2 Earnings Call Highlightsmarketbeat.com
Inspire Medical Systems (NYSE:INSP) reported second-quarter revenue of $200.6 million, down 7.6% from a year earlier, as coding and reimbursement disruptions continued to affect procedure volumes. The company said results exceeded its internal expectations for profitability and cash flow, prompting
Via MarketBeat · August 3, 2026
Inspire Medical Systems (NYSE:INSP) Reports Bullish Q2 CY2026, Stock Jumps 13.6%
Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q2 CY2026 results exceeding the market’s revenue expectations, but sales fell by 7.6%...
Via StockStory · August 3, 2026
Stay updated with the stocks that are on the move in today's after-hours session.chartmill.com
Via Chartmill · August 3, 2026
Mobia Medical Appoints Myriam Curet, M.D., to its Board of Directors
AUSTIN, Texas, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced the appointment of Myriam Curet, M.D., to the Board as an independent director, effective July 30, 2026.
By Mobia Medical, Inc. · Via GlobeNewswire · August 3, 2026